Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | G Curigliano, H Gelderblom, N Mach, T Doi, WMD Tai, P Forde, J Sarantopoulos, PL. Bedard, C-C Lin, S Hodi, S Wilgenhof, A Santoro, C Sabatos-Peyton, T Longmire, K Wan, P Nikolopoulos, L Manenti, A Naing | ||||||||||||
Title | Phase (Ph) I/II study of MBG453± spartalizumab (PDR001) in patients (pts) with advanced malignancies | ||||||||||||
|
|||||||||||||
URL | https://www.abstractsonline.com/pp8/#!/6812/presentation/9834 | ||||||||||||
Abstract Text | AACR Annual Meeting 2019, Abstract CT183 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|